Published in Neurobiol Aging on August 05, 2009
Phosphorylation of tau at Thr212, Thr231, and Ser262 combined causes neurodegeneration. J Biol Chem (2010) 1.16
The role of tau kinases in Alzheimer's disease. Curr Opin Drug Discov Devel (2010) 1.15
Modes of Aβ toxicity in Alzheimer's disease. Cell Mol Life Sci (2011) 0.94
Single-molecule tracking of tau reveals fast kiss-and-hop interaction with microtubules in living neurons. Mol Biol Cell (2014) 0.91
Oligomer formation of tau protein hyperphosphorylated in cells. J Biol Chem (2014) 0.86
Hypothermia-induced hyperphosphorylation: a new model to study tau kinase inhibitors. Sci Rep (2012) 0.82
Abnormal tau induces cognitive impairment through two different mechanisms: synaptic dysfunction and neuronal loss. Sci Rep (2016) 0.81
Genotype-specific differences between mouse CNS stem cell lines expressing frontotemporal dementia mutant or wild type human tau. PLoS One (2012) 0.79
Aβ-mediated spine changes in the hippocampus are microtubule-dependent and can be reversed by a subnanomolar concentration of the microtubule-stabilizing agent epothilone D. Neuropharmacology (2016) 0.77
Increased 4R tau expression and behavioural changes in a novel MAPT-N296H genomic mouse model of tauopathy. Sci Rep (2017) 0.75
Presence of a carboxy-terminal pseudorepeat and disease-like pseudohyperphosphorylation critically influence tau's interaction with microtubules in axon-like processes. Mol Biol Cell (2016) 0.75
The sequence of the human genome. Science (2001) 101.55
The impact of patient-centered care on outcomes. J Fam Pract (2000) 15.07
Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol (1995) 9.03
Control of kinetic properties of AMPA receptor channels by nuclear RNA editing. Science (1994) 5.21
The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon. J Neurosci (1992) 5.02
Effects of organizational change in the medical intensive care unit of a teaching hospital: a comparison of 'open' and 'closed' formats. JAMA (1996) 4.71
Divalent ion permeability of AMPA receptor channels is dominated by the edited form of a single subunit. Neuron (1992) 4.53
Relative abundance of subunit mRNAs determines gating and Ca2+ permeability of AMPA receptors in principal neurons and interneurons in rat CNS. Neuron (1995) 4.24
Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions. Cell (1998) 3.59
Impaired electrical signaling disrupts gamma frequency oscillations in connexin 36-deficient mice. Neuron (2001) 3.43
Structural determinants of ion flow through recombinant glutamate receptor channels. Science (1991) 3.18
FGF5 as a regulator of the hair growth cycle: evidence from targeted and spontaneous mutations. Cell (1994) 3.10
A potent pressor response elicited by drinking water. Lancet (1999) 3.02
Effects of concentration-dependent plasma protein binding on ceftriaxone kinetics. Clin Pharmacol Ther (1981) 2.93
NR2A subunit expression shortens NMDA receptor synaptic currents in developing neocortex. J Neurosci (1997) 2.92
Preemption in tobacco control. Review of an emerging public health problem. JAMA (1997) 2.67
Differences in Ca2+ permeability of AMPA-type glutamate receptor channels in neocortical neurons caused by differential GluR-B subunit expression. Neuron (1994) 2.67
Control by asparagine residues of calcium permeability and magnesium blockade in the NMDA receptor. Science (1992) 2.64
Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency. N Engl J Med (2000) 2.53
Cerebellar GABAA receptor selective for a behavioural alcohol antagonist. Nature (1990) 2.50
A molecular determinant for submillisecond desensitization in glutamate receptors. Science (1994) 2.43
Functional and molecular differences between voltage-gated K+ channels of fast-spiking interneurons and pyramidal neurons of rat hippocampus. J Neurosci (1998) 2.40
Use of Arabidopsis mutants and genes to study amide amino acid biosynthesis. Plant Cell (1995) 2.12
Physicians' attitudes about involvement in lethal injection for capital punishment. Arch Intern Med (2000) 2.04
Bordetella holmesii sepsis in an asplenic adolescent. Pediatr Infect Dis J (1995) 2.03
Characterization of Giemsa dark- and light-band DNA. Cell (1982) 1.96
The 1972 Cuban national child growth study as an example of population health monitoring: design and methods. Ann Hum Biol (1975) 1.94
Prehospital and emergency department delays after acute stroke: the Genentech Stroke Presentation Survey. Stroke (2000) 1.94
Paullones are potent inhibitors of glycogen synthase kinase-3beta and cyclin-dependent kinase 5/p25. Eur J Biochem (2000) 1.93
Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein. Acta Neuropathol (2000) 1.92
Confirming positive results of nucleic acid amplification tests (NAATs) for Chlamydia trachomatis: all NAATs are not created equal. J Clin Microbiol (2005) 1.88
European Guidelines for Quality Assurance in Cervical Cancer Screening. Second edition--summary document. Ann Oncol (2010) 1.86
Colour thresholds and receptor noise: behaviour and physiology compared. Vision Res (2001) 1.82
High frequency of apolipoprotein E epsilon4 allele in young individuals with very mild Alzheimer's disease-related neurofibrillary changes. Exp Neurol (1998) 1.82
Calcium-permeable AMPA-kainate receptors in fusiform cerebellar glial cells. Science (1992) 1.69
Role of guanylyl cyclase and cGMP-dependent protein kinase in long-term potentiation. Nature (1994) 1.68
CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons. J Neurosci (1999) 1.66
Pharmacokinetics of cefetamet (Ro 15-8074) and cefetamet pivoxil (Ro 15-8075) after intravenous and oral doses in humans. Antimicrob Agents Chemother (1988) 1.64
Connexin expression in electrically coupled postnatal rat brain neurons. Proc Natl Acad Sci U S A (2000) 1.64
Mycoplasma pneumoniae protein P30 is required for cytadherence and associated with proper cell development. J Bacteriol (1999) 1.62
Tau binds to the distal axon early in development of polarity in a microtubule- and microfilament-dependent manner. J Neurosci (1996) 1.61
Current care of hepatitis C-positive patients by primary care physicians in an integrated delivery system. J Am Board Fam Pract (2000) 1.61
A phase 3 randomized study of radiotherapy plus procarbazine, CCNU, and vincristine (PCV) with or without BUdR for the treatment of anaplastic astrocytoma: a preliminary report of RTOG 9404. Int J Radiat Oncol Biol Phys (1999) 1.58
A microassay for active and total renin concentration in human plasma based on antibody trapping. Clin Chim Acta (1980) 1.58
Efficacy of tissue plasminogen activator administration on patency of hemodialysis access catheters. Am J Kidney Dis (2000) 1.55
NMDA receptor channels: subunit-specific potentiation by reducing agents. Neuron (1994) 1.55
Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies. J Biol Chem (1999) 1.54
A randomized control trial of two cervical spatulas. Br J Obstet Gynaecol (1991) 1.50
Frequency and severity of vasomotor symptoms among peri- and postmenopausal women in the United States. Climacteric (2008) 1.49
Ability of new APTIMA CT and APTIMA GC assays to detect Chlamydia trachomatis and Neisseria gonorrhoeae in male urine and urethral swabs. J Clin Microbiol (2005) 1.43
The 6-week postnatal visit: are we doing it right? Br J Hosp Med (1995) 1.42
[Passive smoking. Concentrations of smoke constituents in the air of large and small rooms as a function of number of cigarettes smoked and time]. Int Arch Arbeitsmed (1972) 1.41
Allergen challenge increases anandamide in bronchoalveolar fluid of patients with allergic asthma. Clin Pharmacol Ther (2011) 1.41
Cytokine responses correlate differentially with age in infancy and early childhood. Clin Exp Immunol (2005) 1.40
Academic emergency medicine: a national profile with and without emergency medicine residency programs. Ann Emerg Med (1992) 1.39
Sequence of Abeta-protein deposition in the human medial temporal lobe. J Neuropathol Exp Neurol (2000) 1.37
Environmental bias? Effects of housing conditions, laboratory environment and experimenter on behavioral tests. Genes Brain Behav (2006) 1.35
Differential expression of group I metabotropic glutamate receptors in functionally distinct hippocampal interneurons. J Neurosci (2000) 1.35
Optical coherence tomography assessment of the acute effects of stent implantation on the vessel wall: a systematic quantitative approach. Heart (2009) 1.35
Long-term uncoupling of chloride secretion from intracellular calcium levels by Ins(3,4,5,6)P4. Nature (1994) 1.35
Generation of mice with a 200-kb amyloid precursor protein gene deletion by Cre recombinase-mediated site-specific recombination in embryonic stem cells. Proc Natl Acad Sci U S A (1996) 1.32
Differential parallel processing of olfactory information in the honeybee, Apis mellifera L. J Comp Physiol A Neuroethol Sens Neural Behav Physiol (2002) 1.31
Assessment of the pathological stages of Alzheimer's disease in thin paraffin sections: a comparative study. Dement Geriatr Cogn Disord (1998) 1.30
D-myo-Inositol 1,4,5,6-tetrakisphosphate produced in human intestinal epithelial cells in response to Salmonella invasion inhibits phosphoinositide 3-kinase signaling pathways. Proc Natl Acad Sci U S A (1997) 1.30
Sympathetically mediated hypertension in autonomic failure. Circulation (2000) 1.29
Vulnerability of select neuronal types to Alzheimer's disease. Ann N Y Acad Sci (2000) 1.29
Altered autonomic support of arterial blood pressure with age in healthy men. Circulation (2001) 1.28
Expression analysis of green fluorescent protein in retinal neurons of four transgenic mouse lines. Neuroscience (2009) 1.27
PG545, a dual heparanase and angiogenesis inhibitor, induces potent anti-tumour and anti-metastatic efficacy in preclinical models. Br J Cancer (2011) 1.27
Extracellular cAMP is sufficient to restore developmental gene expression and morphogenesis in Dictyostelium cells lacking the aggregation adenylyl cyclase (ACA). Genes Dev (1993) 1.27
Two spatial memories for honeybee navigation. Proc Biol Sci (2000) 1.26
Insulin-like growth factor 1 and a cytosolic tyrosine kinase activate chloride outward transport during maturation of hippocampal neurons. J Neurosci (2001) 1.26
Role of a neuronal small non-messenger RNA: behavioural alterations in BC1 RNA-deleted mice. Behav Brain Res (2004) 1.22
Interaction of tau with the neural membrane cortex is regulated by phosphorylation at sites that are modified in paired helical filaments. J Biol Chem (2000) 1.22
Structural analysis of the glycine-rich, arginine-rich histone. 3. Sequence of the amino-terminal half of the molecule containing the modified lysine residues and the total sequence. J Biol Chem (1969) 1.21
Inflammation and cartilage metabolism in rheumatoid arthritis. Studies of the blood markers hyaluronic acid, orosomucoid, and keratan sulfate. Arthritis Rheum (1990) 1.21
Characterization of Centers for Disease Control group NO-1, a fastidious, nonoxidative, gram-negative organism associated with dog and cat bites. J Clin Microbiol (1993) 1.20
Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy. Basic Res Cardiol (2013) 1.20
Primary hyperparathyroidism presenting as spinal cord compression: report of a case. Aust N Z J Surg (1977) 1.20
The hypertension of autonomic failure and its treatment. Hypertension (1997) 1.18
Molecular cloning of a novel G protein-coupled receptor that may belong to the neuropeptide receptor family. FEBS Lett (1990) 1.17
Autoimmune autonomic ganglionopathy: IgG effects on ganglionic acetylcholine receptor current. Neurology (2007) 1.16
The automatic pilot of honeybees. Proc Biol Sci (2003) 1.15
Argiotoxin detects molecular differences in AMPA receptor channels. Neuron (1993) 1.15
Interaction of von Willebrand factor with human platelets in the plasma milieu. J Clin Invest (1984) 1.15
Thin, stubby or mushroom: spine pathology in Alzheimer's disease. Curr Alzheimer Res (2009) 1.15
Conversion of serine to aspartate imitates phosphorylation-induced changes in the structure and function of microtubule-associated protein tau. J Biol Chem (1997) 1.15
Structural and functional implications of tau hyperphosphorylation: information from phosphorylation-mimicking mutated tau proteins. Biochemistry (2000) 1.14
Evolution of Alzheimer's disease-related cytoskeletal changes in the basal nucleus of Meynert. Acta Neuropathol (2000) 1.14
HDL-cholesterol-raising effect of orange juice in subjects with hypercholesterolemia. Am J Clin Nutr (2000) 1.14
The progression of Alzheimer's disease from limbic regions to the neocortex: clinical, radiological and pathological relationships. Dement Geriatr Cogn Disord (1999) 1.14
Modern concepts in antiglaucomatous implant surgery. Graefes Arch Clin Exp Ophthalmol (2008) 1.13
Radiosurgery for the treatment of previously irradiated recurrent primary brain tumors and brain metastases: initial report of radiation therapy oncology group protocol (90-05). Int J Radiat Oncol Biol Phys (1996) 1.13
Cell-permeable non-hydrolyzable cAMP derivatives as tools for analysis of signaling pathways controlling gene regulation in Dictyostelium. J Biol Chem (1993) 1.13
[Continuous lengthening of the femur with intramedullary stabilisation (author's transl)]. Arch Orthop Unfallchir (1975) 1.13
Gender and age modify the association between APOE and AD-related neuropathology. Neurology (2001) 1.12
Functions and malfunctions of the tau proteins. Cell Mol Life Sci (2002) 1.12
Acidosis reduces NMDA receptor activation, glutamate neurotoxicity, and oxygen-glucose deprivation neuronal injury in cortical cultures. Brain Res (1990) 1.11
Genetically altered AMPA-type glutamate receptor kinetics in interneurons disrupt long-range synchrony of gamma oscillation. Proc Natl Acad Sci U S A (2001) 1.11